ATE246507T1 - Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate - Google Patents

Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate

Info

Publication number
ATE246507T1
ATE246507T1 AT00925158T AT00925158T ATE246507T1 AT E246507 T1 ATE246507 T1 AT E246507T1 AT 00925158 T AT00925158 T AT 00925158T AT 00925158 T AT00925158 T AT 00925158T AT E246507 T1 ATE246507 T1 AT E246507T1
Authority
AT
Austria
Prior art keywords
anthracycline
preparations containing
platinum derivatives
combined preparations
containing morpholine
Prior art date
Application number
AT00925158T
Other languages
English (en)
Inventor
Maria Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of ATE246507T1 publication Critical patent/ATE246507T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00925158T 1999-04-29 2000-04-04 Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate ATE246507T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909925.1A GB9909925D0 (en) 1999-04-29 1999-04-29 Combined preparations comprising anthracycline derivatives
PCT/EP2000/002923 WO2000066093A2 (en) 1999-04-29 2000-04-04 Combined preparations comprising morpholine anthracyclines and anticancer agent

Publications (1)

Publication Number Publication Date
ATE246507T1 true ATE246507T1 (de) 2003-08-15

Family

ID=10852508

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03075776T ATE398457T1 (de) 1999-04-29 2000-04-04 Kombinationspräparat enthaltend ein morpholinyl anthracyclinderivat und einen topoisomerase ii inhibitor
AT00925158T ATE246507T1 (de) 1999-04-29 2000-04-04 Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03075776T ATE398457T1 (de) 1999-04-29 2000-04-04 Kombinationspräparat enthaltend ein morpholinyl anthracyclinderivat und einen topoisomerase ii inhibitor

Country Status (16)

Country Link
US (2) US6537990B1 (de)
EP (3) EP1173187B1 (de)
JP (1) JP2002543112A (de)
CN (5) CN1222294C (de)
AR (1) AR023616A1 (de)
AT (2) ATE398457T1 (de)
AU (1) AU4397700A (de)
DE (2) DE60039260D1 (de)
DK (1) DK1173187T3 (de)
ES (2) ES2204572T3 (de)
GB (1) GB9909925D0 (de)
HK (1) HK1045462B (de)
MY (1) MY136610A (de)
PT (1) PT1173187E (de)
TW (1) TWI222863B (de)
WO (1) WO2000066093A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) * 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
IL157443A0 (en) * 2001-03-14 2004-03-28 Bristol Myers Squibb Co Pharmaceutical compositions for the treatment of cancer including an epothilone analog and a chemotherapeutic agent
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
CA2472578A1 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
US20060264388A1 (en) * 2003-02-26 2006-11-23 Olga Valota Method for treating liver cancer by intrahepatic administration of nemorubicin
AU2004222527A1 (en) * 2003-03-18 2004-09-30 Pharmacia Italia Spa Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor
CN100500212C (zh) * 2005-04-06 2009-06-17 山东蓝金生物工程有限公司 一种抗实体肿瘤药物组合物
RU2423381C2 (ru) 2005-07-25 2011-07-10 Трабьон Фармасьютикалз, Инк. Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул
US7776832B2 (en) * 2006-04-21 2010-08-17 Gem Pharmaceuticals, Llc Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
NZ573646A (en) 2006-06-12 2012-04-27 Wyeth Llc Single-chain multivalent binding proteins with effector function
US20090004134A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane
US20100104566A1 (en) * 2007-01-29 2010-04-29 Nerviano Medical Sciences S.R.L. Antitumor combination comprising a morpholinyl anthracycline and an antibody
JP5302300B2 (ja) 2007-05-11 2013-10-02 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ アンスラサイクリンの医薬組成物
US20110021517A1 (en) * 2008-02-26 2011-01-27 Nerviano Medical Sciences S.R.L. Antitumor combination comprising a morpholinyl anthracycline derivative and demethylating agents
RU2531754C2 (ru) * 2008-04-11 2014-10-27 ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ,ЭлЭлСи,US Связывающееся с cd37 иммунотерапевтическое средство и его комбинация с бифункциональным химиотерапевтическим средством
US8690833B2 (en) 2011-01-31 2014-04-08 Vascular Pathways, Inc. Intravenous catheter and insertion device with reduced blood spatter
WO2016105499A1 (en) 2014-12-23 2016-06-30 Intellectual Property Associates, Llc Methods and formulations for transdermal administration
WO2017053469A2 (en) 2015-09-21 2017-03-30 Aptevo Research And Development Llc Cd3 binding polypeptides
EP3681479B1 (de) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Natriumhydrogencarbonat zur verwendung in der behandlung von gicht und verwandten erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
US5902809A (en) * 1997-07-03 1999-05-11 Paracure, Inc. Arglabin compounds and therapeutic uses thereof
GB9806324D0 (en) 1998-03-24 1998-05-20 Pharmacia & Upjohn Spa Antitumour synergetic composition
GB9820012D0 (en) 1998-09-14 1998-11-04 Pharmacia & Upjohn Spa Use of an anthracycline derivative for the treatment of a liver tumor

Also Published As

Publication number Publication date
CN1535688A (zh) 2004-10-13
AU4397700A (en) 2000-11-17
HK1045462B (zh) 2006-04-28
JP2002543112A (ja) 2002-12-17
US6586428B2 (en) 2003-07-01
ES2307867T3 (es) 2008-12-01
WO2000066093A2 (en) 2000-11-09
DE60004348T2 (de) 2004-02-26
CN1349406A (zh) 2002-05-15
CN1507869A (zh) 2004-06-30
ES2204572T3 (es) 2004-05-01
MY136610A (en) 2008-10-31
DK1173187T3 (da) 2003-10-20
AR023616A1 (es) 2002-09-04
ATE398457T1 (de) 2008-07-15
DE60004348D1 (de) 2003-09-11
CN1222294C (zh) 2005-10-12
EP1977753A1 (de) 2008-10-08
US6537990B1 (en) 2003-03-25
CN1853645A (zh) 2006-11-01
GB9909925D0 (en) 1999-06-30
HK1045462A1 (en) 2002-11-29
EP1173187B1 (de) 2003-08-06
EP1323423B1 (de) 2008-06-18
DE60039260D1 (de) 2008-07-31
PT1173187E (pt) 2003-10-31
TWI222863B (en) 2004-11-01
EP1323423A1 (de) 2003-07-02
US20030087839A1 (en) 2003-05-08
CN1853642A (zh) 2006-11-01
EP1173187A2 (de) 2002-01-23
WO2000066093A3 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
ATE246507T1 (de) Kombinierte vorbereitungen, die morpholin anthracyclin und platin derivate
ZA200102588B (en) Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use.
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
IL152448A0 (en) 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
TR200100054T2 (tr) Paroksetin metansülfonat
MXPA03003246A (es) Derivados de indolina y su uso como ligandos del receptor 5-ht2.
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP0105003A3 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
MXPA02001508A (es) Derivados de arilmetil-carbonilamino-tiazol y sus usos como agentes antitumorales.
PL364825A1 (en) Sapogenin derivatives, their synthesis and use
MXPA03004644A (es) Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales.
HUP0401648A3 (en) 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
DE60132618D1 (de) 4,6-diphenylpyridinderivate als entzündungshemmende mittel
MXPA03000873A (es) Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
HUP0102549A3 (en) Platinum complex, its preparation and therapeutic application
HUP0400551A2 (en) Piperazine derivatives, their preparation and pharmaceutical compositions containing them
DE60127434D1 (de) Benzoxazinonderivative, deren herstellung und verwendung
ATE266637T1 (de) 3,3-biarylpiperidin- und 3,3- biarylmorpholinderivate
DE50002417D1 (de) 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
HUP0203839A3 (en) 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173187

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee